WO0161007A3
Fibroblast growth factor-23 molecules and uses thereof
Abstract
The present invention provides Fibroblast Growth Factor-23 (FGF-23) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGF-23 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGF-23 polypeptides.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0060085A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO0060085A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO0073454A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO0073454A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO0149740A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO0149740A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
| WO9927100A1 | Cites | World Intellectual Property Organization (WIPO) | International search |
10 priority claims, no other members on record
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 18244200 | United States of America | P | |
| 19890300 | United States of America | P | |
| 74858101 | United States of America | A | |
| 09784581 | – | – | – |
| 60182442 | – | – | – |
| 60182442 | – | – | – |
| 60198903 | – | – | – |
| US20000182442P | – | – | – |
| US20000198903P | – | – | – |
| US20010748581 | – | – | – |
19 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)DPE2 | DPE2 | |
| Wipo information: withdrawn in national officeWithdrawnWWW | WWW | |
| Procedure relating to pct application: ceased to have effect for deCeased8642 | 8642 | |
| Wipo information: published in national officeWWP | WWP | |
| Wipo information: entry into national phaseWWE | WWE | |
| Entry into the national phaseENP | ENP | |
| Wipo information: entry into national phaseWWE | WWE | |
| Wipo information: entry into national phaseWWE | WWE | |
| Wipo information: entry into national phaseWWE | WWE | |
| Wipo information: entry into national phaseWWE | WWE | |
| Designated statesAK | AK | |
| Designated countries for regional patentsAL | AL | |
| Corrected version of pamphletCOP | COP | |
| Designated statesAK | AK | |
| Designated countries for regional patentsAL | AL | |
| Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)DFPE | DFPE | |
| Ep: the epo has been informed by wipo that ep was designated in this application121 | 121 | |
| Designated statesAK | AK | |
| Designated countries for regional patentsAL | AL |
Numbers
- Publication
- 01/61007
- Publication, DOCDB
- 0161007
- Publication, EPODOC
- WO0161007
- Application
- 104778
- Application, DOCDB
- 0104778
- Application, EPODOC
- WO2001US04778
Titles2
- English
- FIBROBLAST GROWTH FACTOR-23 MOLECULES AND USES THEREOF
- French
- MOLECULES DU FACTEUR 23 DE CROISSANCE DE FIBROBLASTES ET PROCEDES D'UTILISATION CORRESPONDANTS
Classification
- CPC, 8
- A61K38/1825
- A61P1/04
- A61P1/16
- A61P3/10
- A61P11/00
- A61P17/02
- A61P17/14
- C07K14/50
- IPC, 29
- A01K67 027
- A61K9 00
- A61K38 18
- A61K38 22
- A61K39 395
- A61K45 00
- A61P1 04
- A61P1 16
- A61P3 10
- A61P11 00
- A61P17 02
- A61P17 14
- C07K14 50
- C07K16 22
- C07K16 42
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- C12N15 09
- C12N15 12
- C12N15 62
- C12N15 86
- C12P21 02
- C12P21 08
- C12Q1 02
- C12Q1 68
- G01N33 68
Designated states105
- Regional, 59
- African Regional Intellectual Property Organization (ARIPO)
- Ghana
- Gambia
- Kenya
- Lesotho
- Malawi
- Mozambique
- Sudan
- Sierra Leone
- Eswatini
- United Republic of Tanzania
- Uganda
- Zimbabwe
- Eurasian Patent Organization (EAPO)
- Armenia
- Azerbaijan
- Belarus
- Kyrgyzstan
- Kazakhstan
- Republic of Moldova
- Russian Federation
- Tajikistan
- Turkmenistan
- European Patent Office (EPO)
and 35 moreShow fewer
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye
- African Intellectual Property Organization (OAPI)
- Burkina Faso
- Benin
- Central African Republic
- Congo
- Côte d’Ivoire
- Cameroon
- Gabon
- Guinea
- Guinea-Bissau
- Mali
- Mauritania
- Niger
- Senegal
- Chad
- Togo
- National, 46
- United Arab Emirates
- Albania
- Australia
- Bosnia and Herzegovina
- Barbados
- Bulgaria
- Brazil
- Canada
- China
- Cuba
- Czechia
- Estonia
- Grenada
- Georgia
- Croatia
- Hungary
- Indonesia
- Israel
- India
- Iceland
- Japan
- Democratic People’s Republic of Korea
- Republic of Korea
- Saint Lucia
and 22 moreShow fewer
- Sri Lanka
- Liberia
- Lithuania
- Latvia
- Madagascar
- North Macedonia
- Mongolia
- Mexico
- Norway
- New Zealand
- Poland
- Romania
- Singapore
- Slovenia
- Slovakia
- Trinidad and Tobago
- Ukraine
- United States of America
- Uzbekistan
- Viet Nam
- Yugoslavia, later Serbia and Montenegro (until 2006)
- South Africa